Genetic variation in thrombin-activatable fibrinolysis inhibitor is associated with the risk of diabetic nephropathy

✍ Scribed by Xu, C.-W.; Wu, X.-B.; Ma, X.-L.; Wang, Y.-S.; Zhang, B.-C.; Zhao, J.-J.; Wang, Z.-J.; Chen, J.

• Book ID: 125336326
• Publisher: Springer-Verlag
• Year: 2012
• Tongue: English
• Weight: 165 KB
• Volume: 35
• Category: Article
• ISSN: 0391-4097
• DOI: 10.1007/BF03345800